A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers

A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers

ObjectiveThe aim of this study was to evaluate whether a predictive model based on a contrast enhanced ultrasound (CEUS)-based nomogram and clinical features (Clin) could differentiate Her-2-overexpressing breast cancers from other breast cancers.MethodsA total of 152 pathology-proven breast cancers...

Full description

Bibliographic Details
Main Authors: Zi-mei Lin, Ting-ting Wang, Jun-Yan Zhu, Yong-yuan Xu, Fen Chen, Pin-tong Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
microbubbles
ultrasonography
breast cancer
biomarkers
nomogram
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1035645/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1035645/full

Similar Items